A concentration addition model for the activation of the constitutive androstane receptor by xenobiotic mixtures.
The effects of contaminants are typically studied in individual exposures; however, environmental exposures are rarely from a single contaminant. Therefore, the study of chemical mixtures is important in determining the effects of xenobiotics. The constitutive androstane receptor (CAR) responds to endobiotics and xenobiotics, and in turn induces detoxification enzymes involved in their elimination. First, we compared several androgens as inverse agonists, including androgens allegedly used by Bay Area Laboratory Co-operative to enhance athletic performance. CAR inverse agonists ranked in order of potency were dihydroandrosterone (DHA) > tetrahydrogestrinone (THG) > androstanol > norbolethone. Therefore, we used DHA as an inverse agonist during transactivation assays. Next, we examined the effects of several pesticides, plasticizers, steroids, and bile acids on CAR activation. Our data demonstrates that several pesticides and plasticizers, including diethylhexylphthalate, nonylphenol, cypermethrin, and chlorpyrifos activate CAR. Both full and partial CAR activators were discovered, and EC(50) values and Hillslopes were determined for use in the concentration addition models. Concentration addition models with and without restraint values to account for partial activators were developed. Measured results from transactivation assays with a mixture of two to five chemicals indicate that the concentration addition model without restraints correctly predicts activity unless all of the chemicals in the mixture are partial activators, and then restraint values be considered. Overall, our data indicates that it is important to consider that we are exposed to a milieu of chemicals, and the efficacy of each individual chemical is not the sole factor in determining CAR's activity in mixture modeling.
Baldwin
William S
WS
Institute of Environmental Toxicology, Clemson University, Pendleton, South Carolina 29670, USA. Baldwin@clemson.edu
Roling
Jonathan A
JA
D000465:Algorithms; D000728:Androgens / Q000819:agonists / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D045424:Complex Mixtures / Q000494:pharmacology; D000090702:Constitutive Androstane Receptor; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects; D015386:Hazardous Substances / Q000494:pharmacology*; D051379:Mice; D008954:Models, Biological; D008956:Models, Chemical; D011725:Pyridines / Q000494:pharmacology; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D015533:Transcriptional Activation / Q000187:drug effects; D015262:Xenobiotics / Q000494:pharmacology*
D000728:Androgens; D045424:Complex Mixtures; D000090702:Constitutive Androstane Receptor; D015386:Hazardous Substances; D011725:Pyridines; D018160:Receptors, Cytoplasmic and Nuclear; D015262:Xenobiotics; C028474:1,4-bis(2-(3,5-dichloropyridyloxy))benzene